Glenmede Trust CO Na Coherus Bio Sciences, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $387,488 - $543,644	-30,559 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $395,739 - $470,914	30,559 New	30,559 $422,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $15,367 - $17,576	-928 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $6,006 - $6,862	345 Added 59.18%	928 $17,000
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $7,965 - $10,576	552 Added 1780.65%	583 $10,000
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $268 - $504	31 New	31 $0

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $71.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.